Last updated: December 28, 2022
Sponsor: Dow University of Health Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Radiculopathy
Spondylolisthesis
Hernia
Treatment
N/AClinical Study ID
NCT05663437
IRB-2696
Ages 30-50 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed and referred females with lumbar disc herniation.
- Have a confirmed L4-S1 lumbar disc herniation through an MRI.
- Postero-lateral Disc herniation of stage I & II.
- Age group of 30-50 years.
- Low back pain radiating to one leg for more than 3 months.
- Positive SLR test reproducing symptoms between 40°-70°.
Exclusion
Exclusion Criteria:
- Spondylolisthesis, spondylitis, and spinal canal stenosis.
- Red flags: spinal tumors, cuada equina syndrome, spinal fractures, osteoporosis,infection.
- Severe vascular disease like DVT.
- Pregnancy and Gynecological problems.
- Psychological disorders affecting subject's ability to follow instructions.
Study Design
Total Participants: 70
Study Start date:
October 06, 2022
Estimated Completion Date:
November 05, 2023
Study Description
Connect with a study center
Dow University of Health Sciences
Karachi, Sindh 74200
PakistanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.